ARTICLE | Company News
Isis, Xenon deal
November 22, 2010 8:00 AM UTC
Xenon partnered with Isis to discover and develop antisense therapeutics to treat anemia of inflammation. Isis will discover candidates against hemochromatosis type 2 juvenile (HFE2) and hepcidin an...